Hangzhou Vinaanco Wins Top Prize at National Disruptive Technology Innovation Competition with Its Pulsed Electric Field Tumor Ablation System

On December 11, 2025, at the Grand Finals of the Disruptive Technology Innovation Competition of the 14th China Innovation and Entrepreneurship Competition, Hangzhou Vinacore stood out from 891 high-quality projects across China by virtue of its exceptional technological innovation capabilities and industry-leading strength, winning the highest award of the competition and becoming a national winner of this edition. This honor not only highlights Hangzhou Vinacore’s profound expertise in the field of disruptive technologies but also injects strong momentum into the company’s future development.

Themed “Gathering Through Innovation, Advancing Toward the New,” this national-level competition, hosted by the Torch High-Tech Industry Development Center of the Ministry of Industry and Information Technology, held its finals in Hangzhou. The event was organized by the Hangzhou Municipal People’s Government, the Zhejiang Provincial Department of Economy and Information Technology, and the Zhejiang Provincial Department of Science and Technology. Since its launch in August 2025, the competition has attracted 891 project registrations from across China, covering six frontier fields: future materials, future manufacturing, future information, future energy, future space, and future health. After multiple rounds of selection, 163 high-quality technological projects with disruptive potential advanced to the finals, fully demonstrating China’s innovative vitality in strategic and forward-looking technology sectors.

Zhang Shouhua, Director of the Department of High-Tech Industry at the Ministry of Industry and Information Technology (MIIT), pointed out in his address that the rapid development of disruptive technologies such as artificial intelligence, quantum information, and bio-manufacturing is becoming a crucial pathway for fostering future industries. He stated that the Central Committee of the Communist Party of China attaches great importance to innovation in disruptive technologies, and the MIIT has strengthened its strategic layout in this area through measures such as the National Key R&D Program and the “open competition” mechanism for future industry innovation tasks. Zhang Shouhua emphasized that the China Innovation and Entrepreneurship Competition has grown into a widely influential brand for innovation and entrepreneurship activities in China. As a key specialized track within the China Innovation and Entrepreneurship Competition, the Disruptive Technology Innovation Competition collected over 2,000 outstanding projects from across the country, establishing itself as an important platform for advancing disruptive technological innovation and cultivating future industries, thereby effectively promoting the scientific layout of new fields and new tracks.

At this competition, Hangzhou Weiner Anke’s core technological breakthroughs and industrialization capabilities with its “Pulse Regeneration, Weiner Empowerment – Weiner Knife Tumor Ablation System” received unanimous recognition from the judges and experts.

Cancer remains a global challenge that humanity is striving to overcome, with a severe treatment landscape. In 2000, our team pioneered a novel cancer therapeutic approach internationally by inducing irreversible electroporation (IRE) in tumor cells using high-voltage pulsed electric fields. This method offers the non-thermal selective advantage of ablating lesions while preserving healthy tissues such as major blood vessels and nerves, thereby breaking through clinical barriers associated with existing therapeutic technologies. Furthermore, its robust immunological response and ability to improve the solid tumor microenvironment position it as a highly effective tool for tumor debulking and as a potent enhancer of immunotherapy and cell therapy, holding broad clinical prospects.

Over more than two decades of sustained research, the team has continuously updated and iterated pulsed electric field technology in response to clinical needs, systematically addressing key clinical challenges. The team developed China’s first steep-pulse therapy device, the world’s first combined steep-pulse therapy device, and the world’s first broadband synergistic steep-pulse tumor treatment system (Vena Knife), all of which have been translated into industrial applications for clinical oncology.

The Weiner Knife represents the latest frontier in pulsed electric field ablation technology. It is the world’s first innovative medical device based on a novel method of wideband synergistic steep-pulse tumor ablation, designed for local ablation of tumors and tissues. This device achieves a clinical breakthrough by enabling procedures under local anesthesia instead of general anesthesia. Furthermore, it features the creatively designed first domestic single-needle irreversible electroporation (IRE) ablation electrode, facilitating a clinical paradigm shift from “multi-needle parallel” to “single-needle ablation.” Technically, it overcomes existing clinical challenges associated with intense muscle contraction and the need for multi-needle ablation. With its internationally pioneering working principle, the Weiner Knife leads globally in both theoretical foundation and technical implementation. Approved for use in medical institutions, it is indicated for the treatment of benign and malignant conditions in organs including the liver, pancreas, lungs, prostate, and thyroid.

Currently, the product has passed the registration testing for Class III medical devices conducted by the National Medical Products Administration (NMPA) and has been approved as an innovative medical device by the Center for Medical Device Evaluation of the NMPA. To date, multi-center clinical trials involving more than 300 cases have been completed at over 20 renowned medical institutions in China, including Beijing Tsinghua Changgung Hospital, Southwest Hospital, Beijing Youan Hospital, and Zhejiang Cancer Hospital. The results have been significant. The product will soon complete its industrial translation, establishing internationally leading core technologies, enhancing China’s independent innovation capability and international influence in high-end physical therapy equipment, and providing a new optional tumor treatment solution for clinical practice.

Winner of the National Award, VenaAnco Joins MIIT’s Premium Enterprise Cultivation SystemVenaAnco is dedicated to the research and development of cutting-edge technologies, actively positioning itself in industrial sectors such as minimally invasive tumor ablation and energy-based surgery. By driving industry transformation through technological innovation, the company’s recent receipt of China’s highest national award serves as a strong endorsement of Hangzhou VenaAnco’s technical prowess, innovative business model, and market prospects, while also standing as a testament to the team’s relentless pursuit of excellence. Following this accolade, VenaAnco will be formally included in the Ministry of Industry and Information Technology’s (MIIT) tiered cultivation system for high-quality enterprises. Moving forward, the company will prioritize securing policy support from key national initiatives, such as the Special Project on Disruptive Technological Innovation, and leverage diversified supporting services including implementation incubation and investment-financing matchmaking. These advantages will inject robust momentum into the team’s continuous technological innovation, R&D, achievement translation, and industrialization, empowering VenaAnco to deepen its expertise in disruptive technologies and create greater industrial and social value.

Standing at a new starting point, Hangzhou Venancor will leverage this award as momentum to continuously increase R&D investment, accelerate breakthroughs in core technologies and their industrialization, actively expand the boundaries of industrial applications, and collaborate with partners to build an innovative ecosystem. This will help China achieve leapfrog development in global disruptive technology fields and contribute greater strength to fostering new-quality productive forces and constructing the future industrial ecosystem.

This honor serves as a powerful testament to Hangzhou VinaAnco’s years-long commitment to its original mission of innovation and its deep dedication to technological R&D, while also marking a significant milestone in the company’s advancement toward a new phase of internationalization and intelligent development. Let us look forward to Hangzhou VinaAnco achieving even greater brilliance in the field of disruptive technologies in the future!